1. Home
  2. EXEL
  3. EXEL News

Latest Exelixis Inc. (EXEL) News on November 27, 2025

MT Newswires

2 days ago

Exelixis Insider Sold Shares Worth $3,046,928, According to a Recent SEC Filing

Kymera Therapeutics Stock Earns 92 RS Rating

Investor's Business Daily

6 months ago

Kymera Therapeutics Stock Earns 92 RS Rating

Share on Social Networks: